# Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

> **NCT01919697** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 2370 (actual)

## Conditions studied

- Chronic Idiopathic Constipation

## Interventions

- **DRUG:** Plecanatide

## Key facts

- **NCT ID:** NCT01919697
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 2370 (ACTUAL)
- **Last updated:** 2019-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01919697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01919697, "Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01919697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*